Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.06 | -6.3829787234 | 0.94 | 0.97 | 0.8615 | 680672 | 0.919874 | CS |
| 4 | -0.1 | -10.2040816327 | 0.98 | 1.01 | 0.852 | 723615 | 0.92008244 | CS |
| 12 | -0.08 | -8.33333333333 | 0.96 | 1.05 | 0.6986 | 1415620 | 0.87896388 | CS |
| 26 | -0.69 | -43.949044586 | 1.57 | 2.18 | 0.6986 | 3152562 | 1.18224512 | CS |
| 52 | -3.27 | -78.7951807229 | 4.15 | 6 | 0.6986 | 2063897 | 1.65716656 | CS |
| 156 | -2.7 | -75.4189944134 | 3.58 | 9.77 | 0.17 | 1706922 | 4.14826927 | CS |
| 260 | -12.93 | -93.6278059377 | 13.81 | 41 | 0.17 | 1464515 | 4.64679128 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
